AZD2624

DRUG3 trials

Sponsors

AstraZeneca

Conditions

HealthySafetySchizophrenia

Phase 1

AZD2624 Multiple Ascending Dose Study in Japan

CompletedNCT00696865

AstraZenecaHealthy, Safety

Start: 2008-05-31End: 2008-08-31Target: 30Updated: 2009-07-16

Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation

CompletedNCT00867685

AstraZenecaHealthy

Start: 2009-03-31End: 2009-04-30Updated: 2009-04-30

Phase 2

Phase IIA Study in Patients With Schizophrenia

CompletedNCT00686998

AstraZenecaSchizophrenia

Start: 2008-05-31End: 2009-03-31Updated: 2013-03-29